N1A.F NAVAMEDIC ASA NK 1

Healthcare Health Care Providers & Services Frankfurt Exchange
0.9860 EUR
Close of Nov 12, 2026
0.9440 2.18
Market cap
EUR 23.6M
P/E
-
P/B
0.79x
ROE
-5.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is N1A.F undervalued?

Graham number

The Graham number of NAVAMEDIC ASA NK 1 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NAVAMEDIC ASA NK 1 fundamental analysis

No fundamental analysis for NAVAMEDIC ASA NK 1 yet.

NAVAMEDIC ASA NK 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NAVAMEDIC ASA NK 1

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinur…

Full company profile